Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Millar

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
British Journal of Pharmacology|August 1, 1997
Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibitionC G Millar, C Thiemermann
Lancet (London, England)|June 26, 1999
Corticosteroids in IgA nephropathyN Ashman, C G Millar, M Yaqoob
Pharmacology & Therapeutics|January 1, 1996
Protection of the myocardium by ischaemic preconditioning: mechanisms and therapeutic implicationsC G Millar, G F Baxter, C Thiemermann
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Ischaemia and reperfusion injury in the kidney: current status and future directionR G Woolfson, C G Millar, G H Neild
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 7, 2005
The use of recombinant factor VIIa for bleeding in paediatric practiceC G Millar, M D Stringer, I Sugarman, et al.
Chest|November 1, 1995
The effect of norepinephrine and dobutamine on bladder epithelial oxygen tensionD M Rosser, R P Stidwill, C G Millar, et al.
Shock (Augusta, Ga.)|June 9, 1998
Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxinG M Wray, C G Millar, C J Hinds, et al.
Redox Report : Communications in Free Radical Research|July 15, 2016
Increased levels of plasma 8-EPI-PGF2α in patients with end stage renal failureJ Nourooz-Zadeh, C G Millar, N K Gopaul, et al.
The Journal of Infection|May 1, 1994
Hepatitis C virus infection in haemodialysis patients: a clinical and virological studyG D Corcoran, N S Brink, C G Millar, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
British Journal of Pharmacology|August 1, 1997
Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibitionC G Millar, C Thiemermann
Lancet (London, England)|June 26, 1999
Corticosteroids in IgA nephropathyN Ashman, C G Millar, M Yaqoob
Pharmacology & Therapeutics|January 1, 1996
Protection of the myocardium by ischaemic preconditioning: mechanisms and therapeutic implicationsC G Millar, G F Baxter, C Thiemermann
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Ischaemia and reperfusion injury in the kidney: current status and future directionR G Woolfson, C G Millar, G H Neild
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 7, 2005
The use of recombinant factor VIIa for bleeding in paediatric practiceC G Millar, M D Stringer, I Sugarman, et al.
Chest|November 1, 1995
The effect of norepinephrine and dobutamine on bladder epithelial oxygen tensionD M Rosser, R P Stidwill, C G Millar, et al.
Shock (Augusta, Ga.)|June 9, 1998
Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxinG M Wray, C G Millar, C J Hinds, et al.
Redox Report : Communications in Free Radical Research|July 15, 2016
Increased levels of plasma 8-EPI-PGF2α in patients with end stage renal failureJ Nourooz-Zadeh, C G Millar, N K Gopaul, et al.
The Journal of Infection|May 1, 1994
Hepatitis C virus infection in haemodialysis patients: a clinical and virological studyG D Corcoran, N S Brink, C G Millar, et al.
Pageof 1